Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Teva Pharma Industries Ltd ADR (TEVAN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
242.00 +0.00    +0.00%
29/04 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 242.00 - 242.00
Type:  Equity
Market:  Mexico
ISIN:  US8816242098 
S/N:  881624209
Teva ADR 242.00 +0.00 +0.00%

NYSE:TEVAN Financials

 
This summary provides an overview of the most significant critical numbers from each of the Teva financial reports, including theTeva Pharma Industries Ltd ADR income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:TEVA financials over time via breakdowns of their annual reports.

Teva Pharmaceutical Industries Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 15,846 million compared to USD 14,925 million a year ago. Net loss was USD 559 million compared to USD 2,446 million a year ago. Basic loss per share from continuing operations was USD 0.5 compared to USD 2.2 a year ago. Diluted loss per share from continuing operations was USD 0.5 compared to USD 2.2 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

TEVAN Income Statement & Profits

Gross margin TTM 48.25%
Operating margin TTM 20.07%
Net Profit margin TTM -3.53%
Return on Investment TTM 9.11%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 4457 3850 3878 3661
Gross Profit 2416 1851 1796 1582
Operating Income 1250 761 670 498
Net Income 429 80 -863 -205

TEVAN Balance Sheet

Quick Ratio MRQ 0.54
Current Ratio MRQ 1.02
LT Debt to Equity MRQ 241.95%
Total Debt to Equity MRQ 270.09%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 43479 42088 43095 43456
Total Liabilities 35353 34577 35387 34845
Total Equity 8126 7511 7708 8611

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 1.22
Revenue/Share TTM 14.14
Operating Cash Flow  9.67%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1184 5 324 -145
Cash From Investing Activities 301 184 302 181
Cash From Financing Activities -576 -576 -55 -706
Net Change in Cash 977 -420 494 -658
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Price Commentary

Write your thoughts about Teva Pharma Industries Ltd DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rafi Shoev
Rafi Shoev 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva prduse more than 200 difrent medicatio.to more than 300 milion oeople ebry day.
Rafi Shoev
Rafi Shoev 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva will soply madication to china
Rafi Shoev
Rafi Shoev Apr 30, 2024 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva will provide biosimilar to Humira in USA.
Rafi Shoev
Rafi Shoev Apr 30, 2024 10:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My only astimation fore 2030 teva reach $240????no recomendation
Rafi Shoev
Rafi Shoev Apr 29, 2024 20:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The one fectore that teva will probably sell for more than 2bilion dolars.
Rafi Shoev
Rafi Shoev Apr 29, 2024 19:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Evrey single moment in teva laboratores they work on 40 difrent new medications.
Rafi Shoev
Rafi Shoev Apr 29, 2024 19:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2030 will teva reach $240
Rafi Shoev
Rafi Shoev Apr 29, 2024 18:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva is jaint multy global vompany and stock are so chip???
Rafi Shoev
Rafi Shoev Apr 29, 2024 18:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14.4 amaizing
Rafi Shoev
Rafi Shoev Apr 29, 2024 18:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14.4breavk point.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email